Korean J Nephrol.  2003 Nov;22(6):731-735.

Severe Hypercalcemia in Oliguric Phase of Acute Renal Failure Associated with Rhabdomyolysis

Affiliations
  • 1Department of Internal Medicine, National Police Hospital, Seoul, Korea. puspen@hanmail.net

Abstract

Hypercalcemia rarely develops in patients with acute renal failure associated with rhabdomyolysis. If hypercalcemia occurs, it happens mostly in diuretic phase and rarely in oliguric phase. Secondary hyperparathyroidism, abnormal metabolism of Vitamin D, immobilization of patient, and release of calcium from injured muscle are considered as possible pathogenetic mechanisms of hypercalcemia in acute renal failure associated with rhabdomyolysis. Among them, dissolution of calcium from injured muscle into extracellular fluid is accepted as the major mechanism of pathogenesis of hypercalcemia. A twenty year old male patient, combat policeman, developed syncope in the course of regular physical training. He was diagnosed of acute renal failure associated with rhabdomyolysis at the hospital he initially visited. After being subjected to three sessions of acute hemodialysis, he was transferred to our hospital. During the treatment, laboratory test was performed upon his continuous complaints of lower extremity weakness. It showed severe hypercalcemia with plasma calcium level of 17.6 mg/dL. He was in oliguric phase at the time of this severe hypercalcemia. Patient's lower extremity weakness was gradually improved by hemodialysis using low calcium dialysate. He was discharged after his renal function became normal. He has been followed on regular basis.

Keyword

Hypercalcemia; Oliguric phase; Acute renal failure; Rhabdomyolysis

MeSH Terms

Acute Kidney Injury*
Calcium
Extracellular Fluid
Humans
Hypercalcemia*
Hyperparathyroidism, Secondary
Immobilization
Lower Extremity
Male
Metabolism
Plasma
Renal Dialysis
Rhabdomyolysis*
Syncope
Vitamin D
Calcium
Vitamin D
Full Text Links
  • KJN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr